Cipla launches Yurpeak for treatment of obesity, Type 2 diabetes

Cipla Limited on Wednesday announced the launch of Yurpeak (tirzepatide), a once-weekly injectable therapy for...

Tirzepatide tops semaglutide in trial

Eli Lilly and Company announced on Monday detailed results from SURMOUNT-5, a phase 3b open-label clinical trial,...

New weight loss medication helps lower BP in adults with obesity

According to new research, nearly 500 adults with obesity who took the new weight loss medication tirzepatide for...

New Type 2 diabetes medicine helps maintain weight targets fast

Washington [US], September 18 (ANI): In comparison to other diabetic medications, tirzepatide accomplishes blood...

New type 2 diabetes drug achieves blood sugar targets faster

Washington [US], September 15 (ANI): New research evaluating the time taken to reach blood glucose targets indicates...